Granules India Limited (GRANULES) — Announcement | 13 August 2026
Granules India announced the internal transfer of Chief Strategy Officer Sanjay Kumar to its subsidiary Ascelis Peptides, effective August 13, 2026, where he will assume the CEO role. The filing complies with SEBI Listing Regulations and details the management reshuffle.
About Granules India Limited (GRANULES)
Healthcare · Pharmaceuticals · Listed on NSE
📡 Get AI alerts when GRANULES files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track GRANULES — Free💡 Ask AI about this filing
📊 More GRANULES filings
- 🔴 Announcement — 29 September 2026Granules India announced that the audio recording of its September 29, 2026 investor webinar is now ...
- 🔴 Announcement — 26 September 2026Granules India announced an investor webinar on September 29, 2026, at 4:30 p.m. IST to discuss its ...
- Announcement — 25 September 2026Granules India Ltd announced that its insider trading window will close on October 1, 2026, remainin...
- 🔴 Announcement — 23 September 2026Granules India announced an analyst/investor meeting scheduled for September 28, 2026 in New Delhi, ...
- 🔴 Corporate Action — 16 September 2026Granules India announced the allotment of 2,49,82,906 fully paid-up equity shares of Re. 1 each to p...
🔥 Also filed on 13 August 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when GRANULES files new disclosures
Track GRANULES filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track GRANULES — FreeFree account · 2 AI queries/day